...
机译:P3.01-011对脑转移的EGFR和ALK驱动肺腺癌的比较中国患者预后因子的脑转移
Department of Thoracic Oncology The First Affiliated Hospital of Guangzhou Medical University;
Department of Thoracic Oncology The First Affiliated Hospital of Guangzhou Medical University.;
The First Affiliated Hospital of Guangzhou Medical University.;
Department of Thoracic Oncology The First Affiliated Hospital of Guangzhou Medical University.;
Department of Thoracic Oncology The First Affiliated Hospital of Guangzhou Medical University.;
Department of Thoracic Oncology The First Affiliated Hospital of Guangzhou Medical University.;
机译:P3.01-011对脑转移的EGFR和ALK驱动肺腺癌的比较中国患者预后因子的脑转移
机译:一线表皮生长因子受体(EGFR)-酪氨酸激酶抑制剂单独或与全脑放疗一起用于EGFR突变的肺腺癌患者的脑转移
机译:一线表皮生长因子受体(EGFR)-酪氨酸激酶抑制剂单独或与全脑放疗一起用于EGFR突变型肺腺癌患者的脑转移
机译:Cerna搜索方法鉴定了EGFR DNA扩增肺腺癌患者的核激活的亚组
机译:肾细胞癌患者转移和存活的预后因素分析
机译:一线表皮生长因子受体(EGFR)-酪氨酸激酶抑制剂单独或与全脑放疗一起治疗EGFR突变的肺腺癌患者的脑转移
机译:第一代EGFR-TKI结合脑放射治疗作为肺腺癌患者脑转移和EGFR敏感突变患者的第一线治疗的疗效:回顾性研究